Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

KIR2DL3/CD158b2 Antibody (MM0440-8P9), FITC, Novus Biologicals™
SDP

Mouse Monoclonal Antibody

Supplier:  Novus Biologicals NBP211760F

Catalog No. NBP211760F


Only null left
Add to Cart

Description

Description

KIR2DL3/CD158b2 Monoclonal specifically detects KIR2DL3/CD158b2 in Human samples. It is validated for Flow Cytometry.
Specifications

Specifications

KIR2DL3/CD158b2
Monoclonal
FITC
PBS with 0.05% Sodium Azide
KIR2DL3
Human recombinant KIR2DL3/CD158b2
0.1 mL
Primary
Human
Purified
Flow Cytometry
MM0440-8P9
Flow Cytometry
CD158 antigen-like family member B2, CD158b2 antigen, CD158B2CD158b, cl-6, killer cell immunoglobulin-like receptor 2DL3, killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3, Killer inhibitory receptor cl 2-3, KIR-023GB, KIRCL23, KIR-K7b, KIR-K7c, MGC129943, MHC class I NK cell receptor, natural killer associated transcript 2, natural killer cell inhibitory receptor KIR2DL3, Natural killer-associated transcript 2, NKAT, nkat2, NKAT-2, NKAT2a, NKAT2B, NKAT2GL183, NK-receptor, p58, p58 natural killer cell receptor clone CL-6, p58 NK receptor CL-6, p58.2 MHC class-I specific NK receptor, p58.2 MHC class-I-specific NK receptor
Mouse
Protein G purified
Apoptosis
3804
Store at 4C in the dark.
IgG2
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.